AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
3.250
+0.030 (0.93%)
At close: Mar 28, 2024, 4:00 PM
3.330
+0.080 (2.46%)
After-hours: Mar 28, 2024, 7:57 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $95.77 million as of March 28, 2024. Its market cap has decreased by -48.26% in one year.
Market Cap
95.77M
Enterprise Value
-28.05M
1-Year Change
-48.26%
Ranking
Category
Stock Price
$3.25
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $95.77M, a decrease of -65.93%. That is a compound annual growth rate of -41.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 95.80M | 3.23% |
Mar 26, 2024 | 92.80M | -2.83% |
Mar 25, 2024 | 95.50M | -3.54% |
Mar 22, 2024 | 99.00M | 0.61% |
Mar 21, 2024 | 98.40M | 3.04% |
Mar 20, 2024 | 95.50M | 4.60% |
Mar 19, 2024 | 91.30M | 4.10% |
Mar 18, 2024 | 87.70M | -1.68% |
Mar 15, 2024 | 89.20M | -1.33% |
Mar 14, 2024 | 90.40M | 2.03% |
Mar 13, 2024 | 88.60M | 2.67% |
Mar 12, 2024 | 86.30M | -1.60% |
Mar 11, 2024 | 87.70M | 0.69% |
Mar 8, 2024 | 87.10M | -0.34% |
Mar 7, 2024 | 87.40M | 2.34% |
Mar 6, 2024 | 85.40M | 1.79% |
Mar 5, 2024 | 83.90M | 1.45% |
Mar 4, 2024 | 82.70M | -7.29% |
Mar 1, 2024 | 89.20M | 0.68% |
Feb 29, 2024 | 88.60M | -1.34% |
Feb 28, 2024 | 89.80M | 1.35% |
Feb 27, 2024 | 88.60M | -4.83% |
Feb 26, 2024 | 93.10M | 1.31% |
Feb 23, 2024 | 91.90M | -6.61% |
Feb 22, 2024 | 98.40M | -0.61% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Assertio Holdings | 98.80M |
Alpha Teknova | 98.31M |
LAVA Therapeutics | 97.53M |
Myomo | 96.57M |
BioLineRx | 95.62M |
Forian | 95.09M |
Cardiol Therapeutics | 95.07M |
Barinthus Biotherapeutics | 93.80M |